BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9677380)

  • 1. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein.
    Aberdam E; Bertolotto C; Sviderskaya EV; de Thillot V; Hemesath TJ; Fisher DE; Bennett DC; Ortonne JP; Ballotti R
    J Biol Chem; 1998 Jul; 273(31):19560-5. PubMed ID: 9677380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
    Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
    Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
    Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
    J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation.
    Schwahn DJ; Xu W; Herrin AB; Bales ES; Medrano EE
    Pigment Cell Res; 2001 Feb; 14(1):32-9. PubMed ID: 11277492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive motifs of agouti signal protein.
    Virador VM; Santis C; Furumura M; Kalbacher H; Hearing VJ
    Exp Cell Res; 2000 Aug; 259(1):54-63. PubMed ID: 10942578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of murine melanocyte function in vitro by agouti signal protein.
    Sakai C; Ollmann M; Kobayashi T; Abdel-Malek Z; Muller J; Vieira WD; Imokawa G; Barsh GS; Hearing VJ
    EMBO J; 1997 Jun; 16(12):3544-52. PubMed ID: 9218796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agouti signaling protein and other factors modulating differentiation and proliferation of immortal melanoblasts.
    Sviderskaya EV; Hill SP; Balachandar D; Barsh GS; Bennett DC
    Dev Dyn; 2001 Aug; 221(4):373-9. PubMed ID: 11500974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes.
    Bertolotto C; Abbe P; Hemesath TJ; Bille K; Fisher DE; Ortonne JP; Ballotti R
    J Cell Biol; 1998 Aug; 142(3):827-35. PubMed ID: 9700169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes.
    Gaggioli C; Buscà R; Abbe P; Ortonne JP; Ballotti R
    Pigment Cell Res; 2003 Aug; 16(4):374-82. PubMed ID: 12859621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the transcriptional regulation of melanocytic genes by alphaMSH using the cDNA microarray technique.
    Rouzaud F; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):21-31. PubMed ID: 16914083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
    Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
    Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.
    Khaled M; Larribere L; Bille K; Ortonne JP; Ballotti R; Bertolotto C
    J Invest Dermatol; 2003 Oct; 121(4):831-6. PubMed ID: 14632202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor.
    Jiménez-Cervantes C; Martínez-Esparza M; Pérez C; Daum N; Solano F; García-Borrón JC
    J Cell Sci; 2001 Jun; 114(Pt 12):2335-44. PubMed ID: 11493672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
    Hunt G; Thody AJ
    J Endocrinol; 1995 Nov; 147(2):R1-4. PubMed ID: 7490543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation.
    Martínez-Esparza M; Ferrer C; Castells MT; García-Borrón JC; Zuasti A
    Int J Biochem Cell Biol; 2001 Oct; 33(10):971-83. PubMed ID: 11470231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
    Graham A; Wakamatsu K; Hunt G; Ito S; Thody AJ
    Pigment Cell Res; 1997 Oct; 10(5):298-303. PubMed ID: 9359625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of melanoblast pigmentation by 8-methoxypsoralen:the involvement of microphthalmia-associated transcription factor, the protein kinase a signal pathway, and proteasome-mediated degradation.
    Lei TC; Virador V; Yasumoto K; Vieira WD; Toyofuku K; Hearing VJ
    J Invest Dermatol; 2002 Dec; 119(6):1341-9. PubMed ID: 12485437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.
    Abdel-Malek ZA; Scott MC; Furumura M; Lamoreux ML; Ollmann M; Barsh GS; Hearing VJ
    J Cell Sci; 2001 Mar; 114(Pt 5):1019-24. PubMed ID: 11181184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
    Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
    Shimoda H; Shan SJ; Tanaka J; Maoka T
    J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.